All doses of the diabetes and weight management injectable tirzepatide (Mounjaro, Zepbound) were taken off the FDA's shortage ...

Dumb Blonde” podcast host Bunnie XO said she’s already lost more than a pound — but said she's “microdosing” tirzepatide ...

A recent study found that tirzepatide, the active ingredient in Zepbound and Mounjaro, could reduce the risk of ...

If you're like the vast majority of individual investors, you've never heard of Scholar Rock, apitegromab, or the ...

BMO Capital Markets analyst Evan Seigerman called it “another positive indication” for Eli Lilly, whose top-selling diabetes ...

To date, a number of clinical trials have shown weight regain after discontinuing GLP-1 drugs. In the STEP 1 trial extension, ...

Tirzepatide, a dual GIP and GLP-1 receptor agonist, has gained widespread recognition for its effectiveness in promoting substantial weight loss by enhancing metabolic functions and controlling ...

A woman who started taking a popular weight loss medication through a clinical trial had to look for alternatives when her ...

NHS England plans a phased rollout of tirzepatide to treat severe obesity, with early trials showing significant weight loss.

Patients in England likely to achieve the greatest clinical benefit from shedding weight will be prioritised to receive ...

In an interview with Peers & Perspectives in Oncology, Sherry Shen, MD, discusses the GLP-1 agonists analyzed for weight ...